Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06374810 · ClinicalTrials.gov registry record · NA
Does Conscious Connected Breathwork Reduce Symptoms of Anxiety?
A NA study of Anxiety, sponsored by Richard Blake.
- Completed
- Registry status
- NA
- Development phase
- 108
- Enrollment target
- 1
- Study location
NCT06374810: Completed NA study of Anxiety, sponsored by Richard Blake.
NCT06374810 is a NA study of Anxiety that has completed, run by Richard Blake. The registered enrollment target is 108 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06374810, a NA study of Anxiety, has completed, sponsored by Richard Blake.
- COMPLETED
- Registry status
- NA
- Development phase
- 108 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to test whether conscious connected breathwork reduces symptoms of anxiety in people with mild to severe anxiety symptoms, as measured by the Zung Self Rating Anxiety Scale. The main questions aims to answer: 1. Does conscious connected breathwork reduce symptoms of anxiety? 2. Does an increased frequency of self-practice lead to even greater reductions of anxiety symptoms. there is a comparison group: Researchers will compare whether people doing the breathwork to see if \[insert effects\]. Participants will participate in 1, 90 minute breath workshop per week for 6 weeks. These sessions will be held on Zoom by 2 facilitators. Participants will also be given a 10 minute recording of a guided conscious connected breathwork session that they will be encouraged to complete daily.
Primary Outcome
Scores on the Zung Self Rating Anxiety Scale - Scores range from a minimum of 20 and a maximum of 80. A higher score indicates more severe symptoms of anxiety than a lower score.
Conditions Studied
Interventions
- BEHAVIORAL Conscious Connected Breathwork
- OTHER Placebo waitlist
Study Locations (1)
California
- CIIS - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2023-09-21 |
| Est. Completion | 2023-12-20 |
| Phase | NA |
What the finished NCT06374810 record still lists
NCT06374810 is an interventional study that assigns participants to a tested intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Conscious Connected Breathwork is the first listed.
NCT06374810 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06374810 about?
NCT06374810 is a clinical study titled "Does Conscious Connected Breathwork Reduce Symptoms of Anxiety?". The goal of this clinical trial is to test whether conscious connected breathwork reduces symptoms of anxiety in people with mild to severe anxiety symptoms, as measured by the Zung Self Rating Anxiety Scale. The main questions aims to answer: 1. Does conscious connected breathwork reduce symptoms...
What is the current status of trial NCT06374810?
This trial is currently completed. It is a NA study. The enrollment target is 108 participants. The study started on 2023-09-21. Estimated completion is 2023-12-20.
What conditions does trial NCT06374810 study?
This clinical trial studies the following conditions: Anxiety.
What interventions are being tested in trial NCT06374810?
The interventions under investigation include: Conscious Connected Breathwork (BEHAVIORAL), Placebo waitlist (OTHER).
Who is sponsoring clinical trial NCT06374810?
This trial is sponsored by Richard Blake, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06374810 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06374810's enrollment target sits among peer trials
108 155th of 364 higher than 208 of 364 other Anxiety trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
-
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
RECRUITING · NA
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02703207 · 108 participants · NA
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
- NCT02744677 · 108 participants · NA
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
- NCT02781883 · 108 participants · Phase 2
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
- NCT03848663 · 108 participants · NA
Visual Remapping to Aid Reading With Field Loss
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI